Neuraxpharm, a leading European specialty pharmaceutical company, today announces its “Change for Health” campaign that aims to increase the acceptance of medical cannabis and provide...
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia (TASE: PNAX), a global pharmaceutical company that develops, manufactures and...
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), has appointed Alfredo Barón as the new Country Manager of Neuraxpharm Spain,...
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today announces the expansion of its business in Southeast Europe through...
Dr. Dadi Segal, CEO of Panaxia Global, said, “After obtaining a marketing permit in Germany, which was a very significant milestone for us, we are proud to...